Yuhuan Shi

Integration of Metabolomics and Transcriptomics To Reveal Metabolic Characteristics and Key Targets Associated with Cisplatin Resistance in Nonsmall Cell Lung Cancer

Yuhuan Shi, Yuanyuan Wang, Wanying Huang et al. · Journal of Proteome Research · 2019 · 40 citations

Medicine, Oncology, Pharmacology +17

Non-target metabolomic analysis reveals the therapeutic effect of Saposhnikovia divaricata decoction on collagen-induced arthritis rats

Yueyue Li, Diya Lv, Rong Liu et al. · Journal of Ethnopharmacology · 2021 · 23 citations

Medicine, Biochemistry, Pharmacology +10

Bis(9)-(−)-Meptazinol, a novel dual-binding AChE inhibitor, rescues cognitive deficits and pathological changes in APP/PS1 transgenic mice

Yuhuan Shi, Wanying Huang, Yu Wang et al. · Translational Neurodegeneration · 2018 · 22 citations · Full text

Medicine, Neurobiology, Pharmacotherapy +17

Synergistic antitumor effect of dual PI3K and mTOR inhibitor NVP‑BEZ235 in combination with cisplatin on drug‑resistant non‑small cell lung cancer cell

Hao Zhu, Yuhuan Shi, Xiuxiu Jiao et al. · Oncology Letters · 2020 · 17 citations · Full text

Medicine, Oncology, Pharmacology +17

Effects of BIS-MEP on Reversing Amyloid Plaque Deposition and Spatial Learning and Memory Impairments in a Mouse Model of β-Amyloid Peptide- and Ibotenic Acid-Induced Alzheimer’s Disease

Yu Wang, Mengjun Shen, Yifan Zhou et al. · Frontiers in Aging Neuroscience · 2019 · 11 citations · Full text

Medicine, Neuroscience, Pharmacology +17